14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.30 $3.29 Thursday, 25th Apr 2024 ABUS stock ended at $2.72. This is 1.09% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.43% from a day low at $2.68 to a day high of $2.75.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Sep 19, 2023 $1.99 $2.00 $1.96 $1.98 459 255
Sep 18, 2023 $2.02 $2.04 $1.98 $1.99 543 078
Sep 15, 2023 $2.05 $2.07 $2.00 $2.04 1 221 218
Sep 14, 2023 $2.03 $2.08 $2.03 $2.05 408 659
Sep 13, 2023 $2.04 $2.06 $2.01 $2.05 627 471
Sep 12, 2023 $2.19 $2.19 $2.02 $2.03 774 180
Sep 11, 2023 $2.13 $2.20 $2.11 $2.20 894 685
Sep 08, 2023 $2.05 $2.11 $2.04 $2.10 657 412
Sep 07, 2023 $2.08 $2.08 $2.05 $2.08 629 255
Sep 06, 2023 $2.03 $2.10 $2.02 $2.08 472 945
Sep 05, 2023 $2.04 $2.05 $2.02 $2.04 592 818
Sep 01, 2023 $2.03 $2.06 $2.02 $2.05 728 897
Aug 31, 2023 $2.01 $2.05 $2.01 $2.03 571 187
Aug 30, 2023 $2.02 $2.05 $2.00 $2.02 516 704
Aug 29, 2023 $2.02 $2.03 $2.01 $2.03 377 248
Aug 28, 2023 $2.03 $2.05 $2.01 $2.02 227 833
Aug 25, 2023 $2.04 $2.05 $2.01 $2.03 290 522
Aug 24, 2023 $2.03 $2.06 $2.02 $2.05 582 192
Aug 23, 2023 $2.04 $2.09 $2.03 $2.05 514 658
Aug 22, 2023 $2.05 $2.11 $2.04 $2.05 474 359
Aug 21, 2023 $2.04 $2.08 $2.01 $2.05 696 331
Aug 18, 2023 $2.05 $2.12 $2.04 $2.06 497 636
Aug 17, 2023 $2.02 $2.15 $2.01 $2.07 1 610 189
Aug 16, 2023 $1.99 $2.08 $1.98 $2.03 1 128 538
Aug 15, 2023 $2.02 $2.03 $1.99 $1.99 690 689
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT